NCT07488195 · NOT YET RECRUITING
A Study Of Phototherapy In Patients With Dementia To Improve BPSD
This trial is testing whether light therapy (phototherapy) can reduce behavioral and psychological symptoms of dementia, such as agitation. Participants are inpatients already admitted to a specific hospital unit with a dementia diagnosis. This is a Phase NA study, meaning it is likely a small feasibility or quality-improvement project rather than a large efficacy trial. Details on the light therapy protocol are limited so far.
You may qualify if
- Adult patients admitted on the inpatient Domitilla 3D or 4D unit.
- Documented diagnosis of dementia or suspected major neurocognitive disorder.
- Presence of BPSD symptoms either clinician documented in EHR or assessed through CMAI-O form
- Have patient consent or have a LAR able to sign the consent on behalf of the patient.
You're excluded if
- Macular degeneration, blindness, or photosensitivity
- Patients that do not have capacity to consent and do not have a legally authorized representative to consent on their behalf
- Recent eye surgery
- Bipolar disorder
- Pregnancy
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-03-23